Selected research
Market Structure
Global Canine Cancer Screening Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Canine Cancer Screening market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Canine Cancer Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Canine Cancer Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Canine Cancer Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Canine Cancer Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Canine Cancer Screening include IDEXX, Mars Pedtcare, Zoetis, PetDx, Molecular Diagnostics (MDxHealth), Biomérieux SA, OncoK9, Antech Diagnostics and VolitionRx Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Canine Cancer Screening market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Canine Cancer Screening and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Canine Cancer Screening revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Canine Cancer Screening market size, projected growth trends, production technologies, key applications, and end-use industries.
Canine Cancer Screening Segment by Company
IDEXX
Mars Pedtcare
Zoetis
PetDx
Molecular Diagnostics (MDxHealth)
Biomérieux SA
OncoK9
Antech Diagnostics
VolitionRx Limited
Oncotect
Heska Corporation
Canine Cancer Screening Segment by Type
Liquid Biopsy (Blood-Based Tests)
Tissue Biopsy
Genomic Testing
Biomarker Tests
Canine Cancer Screening Segment by Application
Veterinary Clinics
Veterinary Hospitals
Other
Canine Cancer Screening Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Cancer Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Canine Cancer Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Cancer Screening.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Canine Cancer Screening in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Canine Cancer Screening industry.
Chapter 3: Detailed analysis of Canine Cancer Screening companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Canine Cancer Screeningrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid Biopsy (Blood-Based Tests)
- Tissue Biopsy
- Genomic Testing
- Biomarker Tests
Applications
- Veterinary Clinics
- Veterinary Hospitals
- Other
Companies covered
- IDEXX
- Mars Pedtcare
- Zoetis
- PetDx
- Molecular Diagnostics (MDxHealth)
- Biomérieux SA
- OncoK9
- Antech Diagnostics
- VolitionRx Limited
- Oncotect
- Heska Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Canine Cancer Screening Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Liquid Biopsy (Blood-Based Tests)
- 1.2.3 Tissue Biopsy
- 1.2.4 Genomic Testing
- 1.2.5 Biomarker Tests
- 1.3 Market Analysis by Application
- 1.3.1 Global Canine Cancer Screening Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Veterinary Clinics
- 1.3.3 Veterinary Hospitals
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Canine Cancer Screening Growth Trends by Region
- 1.5.1 Global Canine Cancer Screening Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Canine Cancer Screening Market Size by Region (2021-2026)
- 1.5.3 Canine Cancer Screening Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Canine Cancer Screening Market Dynamics
- 2.1 Canine Cancer Screening Industry Trends
- 2.2 Canine Cancer Screening Industry Drivers
- 2.3 Canine Cancer Screening Industry Opportunities and Challenges
- 2.4 Canine Cancer Screening Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Canine Cancer Screening Revenue by Company (2021-2026)
- 3.2 Global Canine Cancer Screening Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Canine Cancer Screening Key Company Head office and Area Served
- 3.4 Global Canine Cancer Screening Company, Product Type & Application
- 3.5 Global Canine Cancer Screening Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Canine Cancer Screening Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Canine Cancer Screening Players Market Share by Revenue in 2025
- 3.6.3 2025 Canine Cancer Screening Tier 1, Tier 2, and Tier 3
4 Canine Cancer Screening Market by Type
- 4.1 Global Canine Cancer Screening Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Canine Cancer Screening Market Size by Type (2021-2032)
- 4.3 Global Canine Cancer Screening Market Size Share by Type (2021-2032)
5 Canine Cancer Screening Market by Application
- 5.1 Global Canine Cancer Screening Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Canine Cancer Screening Market Size by Application (2021-2032)
- 5.3 Global Canine Cancer Screening Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 IDEXX
- 6.1.1 IDEXX Company Information
- 6.1.2 IDEXX Business Overview
- 6.1.3 IDEXX Canine Cancer Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 IDEXX Canine Cancer Screening Product Portfolio
- 6.1.5 IDEXX Recent Developments
- 6.2 Mars Pedtcare
- 6.2.1 Mars Pedtcare Company Information
- 6.2.2 Mars Pedtcare Business Overview
- 6.2.3 Mars Pedtcare Canine Cancer Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Mars Pedtcare Canine Cancer Screening Product Portfolio
- 6.2.5 Mars Pedtcare Recent Developments
- 6.3 Zoetis
- 6.3.1 Zoetis Company Information
- 6.3.2 Zoetis Business Overview
- 6.3.3 Zoetis Canine Cancer Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Zoetis Canine Cancer Screening Product Portfolio
- 6.3.5 Zoetis Recent Developments
- 6.4 PetDx
- 6.4.1 PetDx Company Information
- 6.4.2 PetDx Business Overview
- 6.4.3 PetDx Canine Cancer Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 PetDx Canine Cancer Screening Product Portfolio
- 6.4.5 PetDx Recent Developments
- 6.5 Molecular Diagnostics (MDxHealth)
- 6.5.1 Molecular Diagnostics (MDxHealth) Company Information
- 6.5.2 Molecular Diagnostics (MDxHealth) Business Overview
- 6.5.3 Molecular Diagnostics (MDxHealth) Canine Cancer Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Molecular Diagnostics (MDxHealth) Canine Cancer Screening Product Portfolio
- 6.5.5 Molecular Diagnostics (MDxHealth) Recent Developments
- 6.6 Biomérieux SA
- 6.6.1 Biomérieux SA Company Information
- 6.6.2 Biomérieux SA Business Overview
- 6.6.3 Biomérieux SA Canine Cancer Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Biomérieux SA Canine Cancer Screening Product Portfolio
- 6.6.5 Biomérieux SA Recent Developments
- 6.7 OncoK9
- 6.7.1 OncoK9 Company Information
- 6.7.2 OncoK9 Business Overview
- 6.7.3 OncoK9 Canine Cancer Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 OncoK9 Canine Cancer Screening Product Portfolio
- 6.7.5 OncoK9 Recent Developments
- 6.8 Antech Diagnostics
- 6.8.1 Antech Diagnostics Company Information
- 6.8.2 Antech Diagnostics Business Overview
- 6.8.3 Antech Diagnostics Canine Cancer Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Antech Diagnostics Canine Cancer Screening Product Portfolio
- 6.8.5 Antech Diagnostics Recent Developments
- 6.9 VolitionRx Limited
- 6.9.1 VolitionRx Limited Company Information
- 6.9.2 VolitionRx Limited Business Overview
- 6.9.3 VolitionRx Limited Canine Cancer Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 VolitionRx Limited Canine Cancer Screening Product Portfolio
- 6.9.5 VolitionRx Limited Recent Developments
- 6.10 Oncotect
- 6.10.1 Oncotect Company Information
- 6.10.2 Oncotect Business Overview
- 6.10.3 Oncotect Canine Cancer Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Oncotect Canine Cancer Screening Product Portfolio
- 6.10.5 Oncotect Recent Developments
- 6.11 Heska Corporation
- 6.11.1 Heska Corporation Company Information
- 6.11.2 Heska Corporation Business Overview
- 6.11.3 Heska Corporation Canine Cancer Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Heska Corporation Canine Cancer Screening Product Portfolio
- 6.11.5 Heska Corporation Recent Developments
7 North America
- 7.1 North America Canine Cancer Screening Market Size (2021-2032)
- 7.2 North America Canine Cancer Screening Market Size by Type
- 7.2.1 North America Canine Cancer Screening Market Size by Type (2021-2026)
- 7.2.2 North America Canine Cancer Screening Market Size by Type (2027-2032)
- 7.2.3 North America Canine Cancer Screening Market Share by Type (2021-2032)
- 7.3 North America Canine Cancer Screening Market Size by Application
- 7.3.1 North America Canine Cancer Screening Market Size by Application (2021-2026)
- 7.3.2 North America Canine Cancer Screening Market Size by Application (2027-2032)
- 7.3.3 North America Canine Cancer Screening Market Share by Application (2021-2032)
- 7.4 North America Canine Cancer Screening Market Size by Country
- 7.4.1 North America Canine Cancer Screening Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Canine Cancer Screening Market Size by Country (2021-2026)
- 7.4.3 North America Canine Cancer Screening Market Size by Country (2027-2032)
- 7.4.4 North America Canine Cancer Screening Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Canine Cancer Screening Market Size (2021-2032)
- 8.2 Europe Canine Cancer Screening Market Size by Type
- 8.2.1 Europe Canine Cancer Screening Market Size by Type (2021-2026)
- 8.2.2 Europe Canine Cancer Screening Market Size by Type (2027-2032)
- 8.2.3 Europe Canine Cancer Screening Market Share by Type (2021-2032)
- 8.3 Europe Canine Cancer Screening Market Size by Application
- 8.3.1 Europe Canine Cancer Screening Market Size by Application (2021-2026)
- 8.3.2 Europe Canine Cancer Screening Market Size by Application (2027-2032)
- 8.3.3 Europe Canine Cancer Screening Market Share by Application (2021-2032)
- 8.4 Europe Canine Cancer Screening Market Size by Country
- 8.4.1 Europe Canine Cancer Screening Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Canine Cancer Screening Market Size by Country (2021-2026)
- 8.4.3 Europe Canine Cancer Screening Market Size by Country (2027-2032)
- 8.4.4 Europe Canine Cancer Screening Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Canine Cancer Screening Market Size (2021-2032)
- 9.2 China Canine Cancer Screening Market Size by Type
- 9.2.1 China Canine Cancer Screening Market Size by Type (2021-2026)
- 9.2.2 China Canine Cancer Screening Market Size by Type (2027-2032)
- 9.2.3 China Canine Cancer Screening Market Share by Type (2021-2032)
- 9.3 China Canine Cancer Screening Market Size by Application
- 9.3.1 China Canine Cancer Screening Market Size by Application (2021-2026)
- 9.3.2 China Canine Cancer Screening Market Size by Application (2027-2032)
- 9.3.3 China Canine Cancer Screening Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Canine Cancer Screening Market Size (2021-2032)
- 10.2 Asia Canine Cancer Screening Market Size by Type
- 10.2.1 Asia Canine Cancer Screening Market Size by Type (2021-2026)
- 10.2.2 Asia Canine Cancer Screening Market Size by Type (2027-2032)
- 10.2.3 Asia Canine Cancer Screening Market Share by Type (2021-2032)
- 10.3 Asia Canine Cancer Screening Market Size by Application
- 10.3.1 Asia Canine Cancer Screening Market Size by Application (2021-2026)
- 10.3.2 Asia Canine Cancer Screening Market Size by Application (2027-2032)
- 10.3.3 Asia Canine Cancer Screening Market Share by Application (2021-2032)
- 10.4 Asia Canine Cancer Screening Market Size by Country
- 10.4.1 Asia Canine Cancer Screening Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Canine Cancer Screening Market Size by Country (2021-2026)
- 10.4.3 Asia Canine Cancer Screening Market Size by Country (2027-2032)
- 10.4.4 Asia Canine Cancer Screening Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Canine Cancer Screening Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Canine Cancer Screening Market Size by Type
- 11.2.1 South America, Middle East & Africa Canine Cancer Screening Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Canine Cancer Screening Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Canine Cancer Screening Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Canine Cancer Screening Market Size by Application
- 11.3.1 South America, Middle East & Africa Canine Cancer Screening Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Canine Cancer Screening Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Canine Cancer Screening Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Canine Cancer Screening Market Size by Country
- 11.4.1 South America, Middle East & Africa Canine Cancer Screening Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Canine Cancer Screening Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Canine Cancer Screening Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Canine Cancer Screening Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst